Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Ophthalmology|June 29, 2018
Long-term follow-up of cryopreserved amniotic membrane transplant during strabismus reoperations: Up 85 months' follow-upRehab Rashad Kassem, Ahmed Mostafa Kamal, Randa Mohamed Abdel-Moneim El-Mofty, et al.
Photochemistry and Photobiology|September 24, 2004
Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patientsRobert A Weersink, Jason Forbes, Stuart Bisland, et al.
Current Medical Research and Opinion|September 26, 2007
Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension studySimon Hill, Mostafa Elhilali, Richard J Millard, et al.
Urology|August 16, 2005
Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once dailyMark Emberton, Mostafa Elhilali, Haim Matzkin, et al.
The Canadian Journal of Urology|April 5, 2001
Learning needs of Canadian urology residents: a surveyBrian Morris, Gary Browne, Peter Chan, et al.
The Journal of Urology|February 23, 2010
The use of a novel reverse thermosensitive polymer to prevent ureteral stone retropulsion during intracorporeal lithotripsy: a randomized, controlled trialAbhay Rane, Anil Bradoo, Pradeep Rao, et al.
Urology|August 11, 2004
uPM3, a new molecular urine test for the detection of prostate cancerYves Fradet, Fred Saad, Armen Aprikian, et al.
The Journal of Urology|May 24, 2011
Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostateSimone Chevalier, Maurice Anidjar, Eleonora Scarlata, et al.
BJU International|February 12, 2005
Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunctionR Jeroen A van Moorselaar, Rudolf Hartung, Mark Emberton, et al.
BJU International|March 7, 2008
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practiceGuy Vallancien, Mark Emberton, Antonio Alcaraz, et al.
Pageof 4